08045804946
Send Inquiry
NAB PACLIARC 100MG INJ
3500.0 INR/Number
Product Details:
- Pacakaging (Quantity Per Box) 1 vial per box
- Salt Composition Nanoparticle Albumin-Bound Paclitaxel 100mg
- Packaging Type Single-use vial
- Indication For the treatment of metastatic breast cancer, non-small cell lung cancer, pancreatic cancer
- Life Span 24 months from manufacturing date
- Brand Name NAB PACLIARC
- Origin of Medicine India
- Click to View more
X
NAB PACLIARC 100MG INJ Price And Quantity
- 1 Number
- 3500.0 INR/Number
- To be administered by healthcare professionals only
- Hypersensitivity to paclitaxel or albumin
- Monitor for hypersensitivity reactions and bone marrow suppression
- Dilute before administration as per prescribing information
- Antineoplastic agents
- Clear colourless to slightly yellow solution
- Ready-to-use liquid, further dilution required for IV use
- Approved for hospital/oncology use
- Intravenous infusion (IV)
- 24 months
- Prescription only (Rx)
- 1 x 100mg Injection vial with leaflet
NAB PACLIARC 100MG INJ Product Specifications
- NAB PACLIARC
- Adults
- India
- Injectable
- Paclitaxel (as nanoparticle albumin-bound) 100mg per vial
- Administered intravenously in clinical setting; do not self-administer
- As directed by the oncologist
- 24 months from manufacturing date
- 100mg per vial
- For the treatment of metastatic breast cancer, non-small cell lung cancer, pancreatic cancer
- Injection/Liquid
- Allopathic
- Cancer patients as prescribed by physician
- Single-use vial
- Store at 2C-8C, protect from light
- 1 vial per box
- Antineoplastic (anticancer)
- Nanoparticle Albumin-Bound Paclitaxel 100mg
- To be administered by healthcare professionals only
- Hypersensitivity to paclitaxel or albumin
- Monitor for hypersensitivity reactions and bone marrow suppression
- Dilute before administration as per prescribing information
- Antineoplastic agents
- Clear colourless to slightly yellow solution
- Ready-to-use liquid, further dilution required for IV use
- Approved for hospital/oncology use
- Intravenous infusion (IV)
- 24 months
- Prescription only (Rx)
- 1 x 100mg Injection vial with leaflet
NAB PACLIARC 100MG INJ Trade Information
- Cash on Delivery (COD), Cash Advance (CA), Cash in Advance (CID)
- 1000 Number Per Week
- 2 Days
- No
- Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
- All India
Product Description
- Breast Cancer: Advanced or metastatic.
- Pancreatic Cancer: Often combined with other drugs like gemcitabine.
- Non-Small Cell Lung Cancer (NSCLC): Advanced stages.
- Ovarian Cancer.
- AIDS-related Kaposi's Sarcoma (in some contexts).
How it's given
- Intravenous (IV) infusion, sometimes over a shorter period (e.g., 30 mins) compared to standard paclitaxel.
Common Side Effects
- Numbness/tingling (peripheral neuropathy) in hands/feet.
- Tiredness, fatigue.
- Nausea, vomiting, diarrhea.
- Joint and muscle pain.
- Swelling in extremities.
Important Precautions
- Pregnancy/Breastfeeding: Avoid; use effective contraception.
- Liver Problems: Use with caution or avoid.
- Blood Counts: Regular monitoring is needed.
- Allergic Reactions: Potential for serious reactions.
Precision Anticancer Therapy
NAB PACLIARC 100MG INJ harnesses the benefits of paclitaxel in a nanoparticle albumin-bound formulation to support effective cancer treatment. Its design allows for targeted delivery via intravenous infusion under medical supervision, ideal for managing advanced cancers such as metastatic breast, lung, and pancreatic cancers. Using this advanced technology, patients receive established chemotherapeutic efficacy with enhanced solubility and distribution.
Ready for Clinical Use, Safe for Patients
The product is delivered as a clear, colorless to slightly yellow solution, requiring no complex reconstitution, only a straightforward dilution step. From storage at 2C-8C to protected handling by professionals, each measure ensures patient safety and medication integrity. Close monitoring throughout treatment helps minimize risk, notably for hypersensitivity or bone marrow suppression.
FAQ's of NAB PACLIARC 100MG INJ:
Q: How is NAB PACLIARC 100MG INJ administered safely?
A: This medicine is given through intravenous infusion by qualified healthcare professionals in hospital or oncology settings only. It is diluted as per prescribing information and must never be self-administered.Q: What precautions should be observed during treatment with this injection?
A: Patients must be monitored for hypersensitivity reactions and bone marrow suppression. It is vital to inform your doctor about any allergies, ongoing illnesses, or medications, as hypersensitivity to paclitaxel or albumin is a contraindication.Q: When should I expect to receive NAB PACLIARC 100MG INJ during my treatment cycle?
A: The frequency and timing are determined by your oncologist based on your specific cancer type, treatment phase, and overall health. It is generally part of a scheduled chemotherapy regimen, and timing will be explained by the medical team.Q: Where is this medication intended for use?
A: NAB PACLIARC 100MG INJ is for use exclusively in a clinical environment like hospitals or specialized oncology centers under prescription and supervision by cancer care professionals.Q: What is the process for preparing and storing NAB PACLIARC 100MG INJ?
A: The injection is a ready-to-use liquid that requires only further dilution before administration. It should be stored at 2C-8C, protected from light, and used within its 24-month shelf life from the manufacturing date.Q: What are the main benefits of choosing NAB PACLIARC 100MG INJ?
A: This formulation enables efficient drug delivery and absorption, reduces the need for solvents associated with adverse reactions, and is supported by clinical approval for several cancer types. Its single-use vial packaging ensures safety, accuracy, and ease of use during therapy.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMSMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
